Maintenance Therapy with Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
JAMA 314:2535-2543,2511, Stupp, R.,et al, 2015
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
J Natl Cancer Inst 101:946-958, Armstrong,G.T.,et al, 2009
Adult Brainstem Gliomas
Neurol 51:1136-1139, Landolfi,J.C.,et al, 1998
Focal Tectal Tumors:Management and Prognosis
Neurol 44:953-956, Squires,L.A.,et al, 1994
Central Nervous System Germinomas, A Review
Arch Neurol 48:652-657, Horowitz,M.B.&Hall,W.A., 1991
Primary CNS Lymphomas:Natural Hx & Response to Radiation Therapy in 55 Pt with AIDS
J Neurosurg 73:206-211, Baumgartner,J.E.,et al, 1990
Recurrent Glioblastoma Treated with Recombinant Poliovirus
NEJM 379:150-161,194, Desjardins,A., et al, 2018
Short-Course Radiation Plus Temozolomide in Elderly Patients with Glioblastoma
NEJM 376:1027-1037, Perry, J.R.,et al, 2017
Interim Results from the CATNON trial (EORTC study 260-53-22054) of treatment with Concurrent and Adjuvant Temozolomide for 1p/19q non-co-deleted anaplastic glioma: A phase 3, randomized, open-label intergroup study
Lancet 390:1645-1653, Van Den Bent, M.J.,et al, 2017
Bevacizumab in Glioblastoma - Still Much to Learn
NEJM 370:764-765, Fine, H.A., 2014
Malignant Gliomas in Adults
NEJM 359:492-507, Wen,P.Y. &Kesari,S., 2008
Outcome in Adult Low-Grade Glioma: The Impact of Prognostic Factors and Treatment
Neurol 69:1366-1373, Schiff,D.,et al, 2007
Long-Term Outcome of Oligodendrogliomas
Neurol 62:1783-1787, Lebrun,C.,et al, 2004
Gliomatosis Cerebri: Molecular Pathology and Clinical Course
Ann Neurol 52:390-399,389, Herrlinger,U.,et al, 2002
Long-Term Outcome of Low-Grade Oligodendroglioma and Mixed Glioma
Neurol 54:1442-1448,1402, Olson,J.D.,et al, 2000
Which Glioblastoma Multiforme Patient Will Become a Long-Term Survivor? A Population-Based Study
Ann Neurol 46:183-188, Scott,J.N.,et al, 1999
Supratentorial Low Grade Astrocytoma:Prognostic Factors, Dedifferentiation, and the Issue of Early Versus Late Surgery
JNNP 64:581-587, van Veelen,M.L.C.,et al, 1998
Brain Tumors in the Elderly
Arch Neurol 55:922-928, Lowry,J.K.,et al, 1998
Radiotherapy for Malignant Glioma
BMJ 313:1500-1501, Gregor,A.,et al, 1996
Malignant Supratentorial Glioma in the Elderly:Is Radiotherapy Useful
Neurol 47:901-905, Meckling,S.,et al, 1996
Suspected Low-Grade Glioma:Is Deferring Treatment Safe
Ann Neurol 31:431-436, 4371992., Recht,L.D.,et al, 1992
Development of Prognostic Index for Primary Supratentorial Intracerebral Tumours
JNNP 55:271-274, Hutton,J.L.,et al, 1992
Primary Cerebral Lymphoma in Patients with AIDs:MR Findings in 17 Cases
AJR 159:841-847, Cordoliani,Y.,et al, 1992
Effects of Treatment on Long-Term Survivors with Malignant Astrocytomas
Ann Neurol 28:818-822, Imperato,J.P.,et al, 1990
Neonatal Brain Tumors:CT & MR Findings
J Comput Assist Tomogr 12:10-20, Radkowski,M.A.,et al, 1988
Oligodendroglioma:An Analysis of 42 Cases
JNNP 50:304-312, Wilkinson,I.M.S.,et al, 1987
Supratentorial Malignant Gliomas in Childhood:A Review of Fifty Cases
Ann Neurol 22:355-364, Dropcho,E.J.,et al, 1987
Prognostic Factors in Brainstem Gliomas
Neurol 36:602-605, Cohen,M.E.,et al, 1986
Survival of Children with Brain Tumors:SEER Program, 1973-1980
Neurol 36:597-601, Duffner,P.K.,et al, 1986
Cerebral Reticulum Cell Sarcoma
Arch Neurol 36:727, DeCoul,A.A.W.,et al, 1979
Relationship of Lymphocyte Invasion & Survival of Brain Tumor Patients
Ann Neurol 4:219-224, Brooks,W.H.,et al, 1978